Can Psychedelics Help PTSD, Depression, and Alzheimer’s?

Dustin Robinson joins Ryan Alford to discuss the growing body of scientific research surrounding psychedelic medicine and why mental health innovation may be entering a new era. As an attorney, investor, and advocate for responsible legal reform, Dustin explains how compounds once dismissed by society are now being studied for PTSD, depression, anxiety, and neurodegenerative diseases.  Ryan and Dustin explore FDA clinical trials, neuroplasticity, the importance of evidence-based medicine, and why responsible regulation is key to unlocking these therapies safely. They also discuss non-hallucinogenic psychedelics, Alzheimer’s research, virtual reality treatments, and how innovation could reshape the future of behavioral health.  Topics Covered Psychedelic medicine research PTSD and MDMA therapy Depression and psilocybin Neuroplasticity Alzheimer’s and dementia FDA clinical trials Responsible legalization Mental health innovation Virtual reality therapeutics Ryan Alford and Dustin Robinson on the future of behavioral health Links Dustin Robinson Instagram: https://www.instagram.com/dustinr10/ ETHER Investments: https://etherinvestments.com Ryan Alford https://www.instagram.com/ryanalford/ https://vibesciencepodcast.com